SCHEMBL17548425

SCHEMBL17548425

Cc1cccc(CSc2nc(-c3ccccc3)c(Cl)c(=O)[nH]2)c1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 4/20 0.73
MEN1 O00255 7/20 0.60
KMT2A Q03164 7/20 0.60
POLB P06746 5/20 0.60
HPGD P15428 2/20 0.55
ALDH1A1 P00352 2/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TNF P01375 2/20 0.54
NOD2 Q9HC29 2/20 0.54
NOD1 Q9Y239 2/20 0.54
PLA2G1B P04054 1/20 0.54
ATG4B Q9Y4P1 1/20 0.54
BRD4 O60885 1/20 0.54
MAOB P27338 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
DAO P14920 1/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17548422 0.86 ACMSD (0.73) ACMSDMEN1KMT2APOLBHPGD
SCHEMBL17548492 0.84 ACMSD (1.00) ACMSDMEN1KMT2APOLB
SCHEMBL23892607 0.84 ACMSD (0.79) ACMSDMEN1KMT2APOLBHPGD
SCHEMBL17548428 0.78 ACMSD (0.71) ACMSDKMT2AHPGDALDH1A1TP53
SCHEMBL27787215 0.77 ALDH1A1 (0.57) MEN1KMT2AHPGDALDH1A1TP53
SCHEMBL27787217 0.75 HPGD (0.74) MEN1KMT2APOLBHPGDALDH1A1
SCHEMBL27787212 0.75 ALDH1A1 (0.55) MEN1KMT2AHPGDALDH1A1TP53
SCHEMBL9209341 0.72 MAPK14 (0.63) ACMSDHPGDALDH1A1L3MBTL1KDM4E
SCHEMBL20099427 0.72 MEN1 (0.78) ACMSDMEN1KMT2APOLBHPGD
SCHEMBL17548426 0.72 ACMSD (0.74) ACMSDMEN1KMT2APOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362185-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2017-12-21 US disclosed
US-9708272-B2 Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase TES PHARMA S.R.L. (IT) 2017-07-18 US disclosed
US-20160060226-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060226-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885MEN1 2572/4885KMT2A 1353/4885
US-20170362185-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885MEN1 2572/4885KMT2A 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.